Public annual accounts

Bio-Incubator Leuven financials

Name: Bio-Incubator Leuven financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Bio-Incubator Leuven, with comparable measures and links to available source documents.

Company overview

Registry number

0876605232

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for Bio-Incubator Leuven

2025 versus 2024

Operating line: €4,213,701
EBITDA: €3,421,164
Total assets: €44,046,860
Equity: €9,180,699

EBITDA margin +81.2% · Equity ratio +20.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€4,213,701	€3,421,164	€44,046,860	€9,180,699	-
202431 Dec 2024	€3,525,552	€2,790,135	€44,626,732	€9,656,102	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€4,213,701

€3,421,164

€44,046,860

€9,180,699

202431 Dec 2024

€3,525,552

€2,790,135

€44,626,732

€9,656,102